- Home
- CUE vs CMTL Comparison
CUE vs CMTL Comparison
Compare CUE & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- CMTL
- Stock Information
- Founded
- CUE 2014
- CMTL 1967
- Country
- CUE United States
- CMTL United States
- Employees
- CUE N/A
- CMTL N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- CMTL Radio And Television Broadcasting And Communications Equipment
- Sector
- CUE Health Care
- CMTL Technology
- Exchange
- CUE Nasdaq
- CMTL Nasdaq
- Market Cap
- CUE 64.4M
- CMTL 60.4M
- IPO Year
- CUE 2018
- CMTL N/A
- Fundamental
- Price
- CUE $1.25
- CMTL $2.60
- Analyst Decision
- CUE Strong Buy
- CMTL Strong Buy
- Analyst Count
- CUE 5
- CMTL 1
- Target Price
- CUE $5.00
- CMTL $9.25
- AVG Volume (30 Days)
- CUE 971.4K
- CMTL 441.2K
- Earning Date
- CUE 11-14-2024
- CMTL 12-05-2024
- Dividend Yield
- CUE N/A
- CMTL N/A
- EPS Growth
- CUE N/A
- CMTL N/A
- EPS
- CUE N/A
- CMTL N/A
- Revenue
- CUE $9,532,000.00
- CMTL $540,403,000.00
- Revenue This Year
- CUE $104.81
- CMTL $0.96
- Revenue Next Year
- CUE N/A
- CMTL $10.66
- P/E Ratio
- CUE N/A
- CMTL N/A
- Revenue Growth
- CUE 149.53
- CMTL N/A
- 52 Week Low
- CUE $0.45
- CMTL $1.53
- 52 Week High
- CUE $3.25
- CMTL $12.51
- Technical
- Relative Strength Index (RSI)
- CUE 43.10
- CMTL 36.09
- Support Level
- CUE $1.32
- CMTL $2.47
- Resistance Level
- CUE $1.99
- CMTL $2.88
- Average True Range (ATR)
- CUE 0.29
- CMTL 0.30
- MACD
- CUE -0.06
- CMTL -0.04
- Stochastic Oscillator
- CUE 0.67
- CMTL 14.45
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solutions. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. Majority of sales are generated from Satellite and Space Communications segment.